Suchergebnisse - "Stramer, Susan L"

PubPharm (378)

41

The Mirasol Evaluation of Reduction in Infections Trial (MERIT) : study protocol for a randomized controlled clinical trial

enthalten in: Trials | 2022

von Kasirye, R. | Hume, H. | Bloch, E. | +28

42

The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial

enthalten in: Trials | 2022

von Kasirye, R. | Hume, H. | Bloch, E. | +28

43

The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial

enthalten in: Trials | 2022

von Kasirye, R. | Hume, H. | Bloch, E. | +28

44

Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies : Basis for an Expanded National Donor Serosurveillance Program

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Stone, M. | Di Germanio, C. | Wright, D. | +43

45

Patterns of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Among 1.6 Million Blood Donors : Impact of Vaccination, United States, December 2020-June 2021

enthalten in: The Journal of infectious diseases | 2022

von Dodd, R. | Notari, E. | Brodsky, J. | +4

CommentIn: J Infect Dis. 2022 Jan 5;225(1):1-4. - PMID 34626464

46

Babesia blood testing : the first-year experience

enthalten in: Transfusion | 2022

von Tonnetti, L. | Dodd, R. | Foster, G. | +1

47

Background rate of low-level HCV RNA in anti-HCV confirmed-positive and minipool nucleic acid test-nonreactive blood donations

enthalten in: Transfusion | 2022

von Groves, J. | Y Dodd, R. | Zhu, X. | +2

48

Babesia blood testing : the first‐year experience

enthalten in: Transfusion | 2022

von Tonnetti, L. | Dodd, R. | Foster, G. | +1

49

Background rate of low‐level HCV RNA in anti‐HCV confirmed‐positive and minipool nucleic acid test‐nonreactive blood donations

enthalten in: Transfusion | 2022

von Groves, J. | Y. Dodd, R. | Zhu, X. | +2

50

Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction

enthalten in: Transfusion | 2022

von Stramer, S. | Lanteri, M. | Brodsky, J. | +11